NASDAQ: DHCDiversified Healthcare Trust Stock
$1.32+0.00 (+0%)
Updated Mar 24, 2023
DHC Price
$1.32
Fair Value Price
$4.08
Market Cap
$316.38M
52 Week Low
$0.61
52 Week High
$3.28
P/E
-18.86x
P/B
0.12x
P/S
0.12x
PEG
N/A
Dividend Yield
3.03%
Revenue
$1.28B
Earnings
-$15.77M
Gross Margin
13.6%
Operating Margin
15.14%
Profit Margin
-1.2%
Debt to Equity
1.28
Operating Cash Flow
-$40M
Beta
1.54
Next Earnings
May 1, 2023
Ex-Dividend
N/A
Next Dividend
N/A
DHC Overview
DHC is a real estate investment trust, or REIT, that owns medical office and life science properties, senior living communities and wellness centers throughout the United States. DHC is managed by the operating subsidiary of The RMR Group Inc., an alternative asset management company that is headquartered in Newton, MA.
Zen Score
–
Industry Average (30)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how DHC scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
DHC ($1.32) is undervalued by 67.66% relative to our estimate of its Fair Value price of $4.08 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
DHC ($1.32) is significantly undervalued by 67.66% relative to our estimate of its Fair Value price of $4.08 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
DHC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more DHC due diligence checks available for Premium users.
Be the first to know about important DHC news, forecast changes, insider trades & much more!
DHC News
Valuation
DHC fair value
Fair Value of DHC stock based on Discounted Cash Flow (DCF)
Price
$1.32
Fair Value
$4.08
Undervalued by
67.66%
DHC ($1.32) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
DHC ($1.32) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
DHC is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
DHC price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-18.86x
Industry
23.27x
Market
21.37x
DHC price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
0.12x
Industry
1.34x
DHC is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
DHC's financial health
Profit margin
Revenue
$336.9M
Net Income
-$65.3M
Profit Margin
-19.4%
DHC's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$6.0B
Liabilities
$3.4B
Debt to equity
1.28
DHC's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
DHC's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$3.4M
Investing
-$96.0M
Financing
-$13.1M
DHC vs Healthcare Facility REIT Stocks
Diversified Healthcare Trust Stock FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.